2021
DOI: 10.21037/jgo-20-264
|View full text |Cite
|
Sign up to set email alerts
|

Prognosis prediction model for a special entity of gastric cancer, linitis plastica

Abstract: Background: Gastric linitis plastica (GLP) is characteristic by its poor prognosis and highly aggressive characteristics compared with other types of gastric cancer (GC). However, the guidelines have not yet been distinguished between GLP and non-GLP. Methods: A total of 342 eligible patients with GLP identified in the Surveillance, Epidemiology, and End Results (SEER) dataset were randomly divided into training set (n=298) and validation set (n=153). A nomogram would be developed with the constructed predicti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 47 publications
0
0
0
Order By: Relevance
“…Another approach for increasing the OS involves the simultaneous use of pharmacological ascorbate, which, in mouse models, exhibits selective cytotoxicity on cancer cells, along with oxaliplatin, resulting in better outcomes than chemotherapy alone. In a similar pattern, targets in the NAD+ pathway may prove useful in combination with radiotherapy [33]. Future perspectives include controlling immune checkpoint inhibitors, such as those blocking the interaction between PD1 and PD-L1 and utilizing viruses such as G47D, a modified Herpes simplex virus type 1, which has shown encouraging results in mouse models against solid tumors by inhibiting the growth of subcutaneous cancerous cells [33,34].…”
Section: Novel Targets-approachesmentioning
confidence: 99%
See 1 more Smart Citation
“…Another approach for increasing the OS involves the simultaneous use of pharmacological ascorbate, which, in mouse models, exhibits selective cytotoxicity on cancer cells, along with oxaliplatin, resulting in better outcomes than chemotherapy alone. In a similar pattern, targets in the NAD+ pathway may prove useful in combination with radiotherapy [33]. Future perspectives include controlling immune checkpoint inhibitors, such as those blocking the interaction between PD1 and PD-L1 and utilizing viruses such as G47D, a modified Herpes simplex virus type 1, which has shown encouraging results in mouse models against solid tumors by inhibiting the growth of subcutaneous cancerous cells [33,34].…”
Section: Novel Targets-approachesmentioning
confidence: 99%
“…In a similar pattern, targets in the NAD+ pathway may prove useful in combination with radiotherapy [33]. Future perspectives include controlling immune checkpoint inhibitors, such as those blocking the interaction between PD1 and PD-L1 and utilizing viruses such as G47D, a modified Herpes simplex virus type 1, which has shown encouraging results in mouse models against solid tumors by inhibiting the growth of subcutaneous cancerous cells [33,34].…”
Section: Novel Targets-approachesmentioning
confidence: 99%